← Leaderboards
Chaoping Chen
Colorado State University
$2,322,879
Attributed
$4,620,514
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $851.1K · FY2009–23$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,620,514 · 5
By mechanism
R01$3,731,398 · 2
R21$400,008 · 1
R56$340,408 · 1
R03$148,700 · 1
Top collaborators
- Thomas D Y Chung4 shared
- David H Sherman4 shared
- Daniel V. Labarbera3 shared
Most similar at Colorado State University
Same institution · by research overlap
- David H Sherman$25,887,943
- Candace K. Mathiason$12,501,335
- Thomas D Y Chung$4,119,569
- Paul J Laybourn$2,169,316
- Aaron J Sholders$358,116
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsFda ApprovedViralPeptide HydrolasesDrug ResistanceAffinitySagittariaVirionBiochemicalCatalytic DomainReactionProductionLeadSmall MoleculeBaseProtease InhibitorLifeAnalogResistant StrainPol Gene ProductsMediatingHiv-1High Throughput ScreeningInhibitor/Antagonist
Grant awards (12)
HTS Targeting HIV-1 Protease Autoprocessing for First in Class Drug Discovery$510,656
R01 · FY2023 · AI · contact PI
Assay Development and Validation for Precision Antiretroviral Therapy to Combat Drug Resistance$340,408
R56 · FY2023 · AI · contact PI
HTS Targeting HIV-1 Protease Autoprocessing for First in Class Drug Discovery$640,952
R01 · FY2022 · AI · contact PI
HTS Targeting HIV-1 Protease Autoprocessing for First in Class Drug Discovery$636,059
R01 · FY2021 · AI · contact PI
HTS Targeting HIV-1 Protease Autoprocessing for First in Class Drug Discovery$803,950
R01 · FY2020 · AI · contact PI
Assay Development for Identification of HIV-1 Protease Autoprocessing Specific Inhibitors$378,632
R01 · FY2018 · AI · contact PI
Assay Development for Identification of HIV-1 Protease Autoprocessing Specific Inhibitors$378,605
R01 · FY2017 · AI · contact PI
Assay Development for Identification of HIV-1 Protease Autoprocessing Specific Inhibitors$382,544
R01 · FY2016 · AI · contact PI
Assay Optimization for Identification of Novel HIV-1 Protease Autoprocessing Inhi$74,350
R03 · FY2015 · AI · contact PI
Assay Optimization for Identification of Novel HIV-1 Protease Autoprocessing Inhi$74,350
R03 · FY2014 · AI · contact PI
Isolation and Characterization of Aptamers Targeted to Inhibit HIV Protease Matur$182,657
R21 · FY2010 · AI · contact PI
Isolation and Characterization of Aptamers Targeted to Inhibit HIV Protease Matur$217,351
R21 · FY2009 · AI · contact PI